RealFeedApp Bristol Myers Squibb pauses CAR-T autoimmune trials
A patient died from septic pneumonia after receiving investigational CAR-T therapy for multiple sclerosis in a Phase 1 trial. This death adds to growing safety concerns regarding CAR-T treatments for autoimmune conditions.
- Field
- industry news
- What they did
- Bristol Myers Squibb reported the death of a patient who received its investigational CAR-T therapy in an early autoimmune trial.
- Why it matters
- This event adds to existing safety concerns about the growing field of CAR-T research, where transient inflammatory events and other deaths have been observed in recent studies.
#car-t#clinical trial#safety#multiple sclerosis#bristol myers squibb
